Default company panoramic image
53114a63 4831 4282 8a0d c84587815da9

Bioheart, Inc.

Pioneer and undisputed leader in applying adult muscle stem cells to treat advanced heart failure. Only cell type able to grow new muscle.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Sunrise, FL, USA
  • Currency USD
  • Website

Company Summary

Bioheart, Inc. is the first co. to address the underlying cause of heart failure in more than 50 million patients worldwide, which is untreated scar tissue following a heart attack. We began our clinical trials in 2001 and stand 7 years ahead of the nearest competitor in bringing a cell composition able to grow new muscle in heart scar tissue to market. Our Phase II/III MARVEL randomized placebo controlled study demonstrated 500% improvement.


  • Default avatar
    Mike Tomas

    Former Managing Director Astri Capital. Operations Manager with MCi Telecom.

  • Default avatar
    Kristin Comells

    Former stem cell Scientist at Osiris Therapeutics and Tulane University.

  • Default avatar
    Howard John Leonhardt
    Founder, Major Investor, Inventor Prouducts & Chairman Sci Advisory Board

    Inventor with 20 U.S. patents for treating heart disease. Founder of 20 companies. TALENT stent graft invention holds 70% of world market share for thoracic aortic aneurysms. Provided substantial return to investors in previous cos. Former VP Emerging Therapies Medtronic, Inc. Former Chairman & CEO World Medical Mfg. Corp., Chairman The California Stock Exchange, Board Member Cell Therapy Foundation

Previous Investors

  • Default avatar
    St. Jude Medical
    Default avatar
    Boston Scientific Guidant, inc.
    Default avatar
    Abbott Labs